Result of Retail Offer

The Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that the Retail Offer launched on 2 February 2026 has now closed, raising gross proceeds of approximately £0.2 million. Subject to the Retail Offer becoming unconditional, a total of 3,760,473 Retail Offer Shares will be issued at a price of 4.0 pence each.

Following the close of the Retail Offer, the Company has conditionally raised, in aggregate, gross proceeds of approximately £10.8 million at the Issue Price via the Fundraising.

As set out in the Circular published on 2 February 2026, the Retail Offer is conditional on, inter alia, the Resolutions being passed by the Shareholders at the General Meeting to be held on 18 February 2026 and First Admission becoming effective.

Subject to the passing of the Resolutions at the General Meeting, the Company will issue and allot a total of 270,010,473 new Ordinary Shares with regards to the Fundraising. First Admission, in respect of the Firm Placing, Firm Subscription and Retail Offer, of 80,010,473 new Ordinary Shares is expected to occur at 8.00 a.m. on or around 19 February 2026. Subject to the satisfaction of the Condition, Second Admission, in respect of the Conditional Placing, is expected to occur at 8.00 a.m. on or around 9 April 2026, but in any event no later than a longstop date of 6 May 2026. If the Condition is not satisfied by 6 May 2026, the Conditional Placing will not complete and the funds being raised under the Conditional Placing will not be received.

The issued share capital of the Company following the First Admission (including the new Ordinary Shares) (the "First Admission Enlarged Share Capital") will be a total of 613,362,996 Ordinary Shares. Subject to the satisfaction of the Condition, the issued share capital of the Company following the Second Admission (including the new Ordinary Shares) (the "Second Admission Enlarged Share Capital") will be a total of 803,362,996 Ordinary Shares.

A separate announcement will be made following the General Meeting of the results of the General Meeting and the total voting rights following Admission.

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the announcement of the Fundraising made by the Company at 1:01p.m. on 2 February 2026.

UK Product Governance Requirements

EU Product Governance Requirements